Seattle, WA 98195
United States
University of Washington
epatocellular carcinoma (HCC), Intensity modulated proton therapy (IMPT), Proton beam therapy (PBT), radiotherapy, Simultaneous integrated boost/protection (SIB/SIP)
Hepatocellular carcinoma (HCC), Intensity Modulated Proton Therapy (IMPT), proton beam therapy (PBT), radiotherapy, Simultaneous integrated boost/protection (SIB/SIP)
Non small cell lung cancer, Stage IV NSCLC, FDG PET CT, Chemoimmunotherapy, pembrolizumab, Liver SUVmax, Cytokines, T cell receptor diversity, Treatment response prediction, Overall survival, Progression free survival, Imaging biomarkers, Circulating immune biomarkers